Gateway Chemical Technology, Inc. has been renamed IQsynthesis. The company provides custom synthesis and process development and assists the pharmaceutical, agrochemical and specialty chemical industries in the early phase production of molecules for research and development. The new name is part of a re-branding initiative by Chemir Analytical Services, which acquired the company in May 2006.

“Clients have been requesting synthetic chemistry services, and we sought an acquisition to best fill this need,” explains Shri Thanedar, Ph.D., and chief executive officer of Chemir Analytical Services. “We chose the name IQsynthesis to emphasize the high caliber of scientists in this excellent organization. IQsynthesis also reflects our focus on innovation and quality, as we assist companies in the discovery and development of new molecules.”

“These molecules are the first steps in the development of new medications and therapies,” said Robert Kaufman, Ph.D., president of IQsynthesis. “We help large to virtual companies save time, stay on schedule, and attain their goal of creating molecules for a better life.”

Plans are underway to expand laboratory space and staff, as well as develop infrastructure and systems for cGMP regulated synthesis.

“As our Chemir group of companies serves more and more pharmaceutical clients, we understand the need for a broad and diverse offering of contract service providers,” says Dr. Thanedar. Currently, the Chemir group of companies include IQsynthesis, Chemir Analytical Services, Azopharma, a pharmaceutical contract service provider located in Florida, and CAS-MI, a laboratory serving the paints, coatings, and polymer industries, located in Michigan.